7
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Change in Minimal Cross Sectional Area Using the New Nasal Dilator, “Airplus”

, &
Pages 130-132 | Published online: 08 Jul 2009
 

Abstract

In 36 persons without nasal complaints nasal cavities were investigated using acoustic rhinometry (Rhin 2000), to study the effect of a nasal dilator (ND) named “Airplus”. The minimal cross sectional area (MCA) of both the right and left side was assessed before and after application of the ND, and the total MCA was calculated as the sunl of the right and left side. In 8 persons the MCA was measured before and after 2 applications of the ND. In 8 persons the MCA was measured before, immediately after and 2 hours after application of the ND. In trial one the median total MCA was 1.37 cm2 before and 1.96 cm2 after application of the ND. This corresponds to an increase of 43%, p < 0.000 — 01. In trial two the median total MCA was increased from 1.37 cm2 respectively 1.35 cm2 to 1.98 cm2 respectively 2.01 cm2. an increase of 45% respectively 49%, p < 0.008 in both. In trial three the median total MCA was 1.21 cm2 before and 1.95 cm2 immediately after application and 1.93 cm2 after 2 hours. The increase was 61 and 59%. p < 0.008 in both. The results show that the “Airplus” nasal dilator improves significantly the MCA. it was possible to reproduce the effect and it was stable in the recorded period.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.